Nigerian Institute of Medical Research (NIMR) conducted training on Public Service Rules for staff that are relatively new in the system. The training held at the Institute’s Auditorium on Monday, 24 May 2021
Day one of Performance Improvement Staff Training organized by the Nigerian Institute of Medical Research for staff on grade level 3-6. The training held at the Institute’s Biomedical and Cancer Research Centre today Tuesday, 25 May 2021.
The Genomics and Research Management Team of the Medical Research Council, The Gambia at The London School of Hygiene and Tropical medicine (MRCG-LSHTM) led by Dr. Abdul Karim Sesay visited NIMR-Nigeria. The visit was on Capacity development and Technology transfer in Genomics research, and strengthening of collaboration between the two institutions. Other members of the MRCG-LSHTM team are Mr. Abdoulie Kanteh and Mr. Dembo Kanteh.
The MRCG-LSHTM Team facilitated a one-week hands-on SARS-CoV-2 Genome sequencing training using the Oxford Nanopore Sequencing Platform while on the visit to NIMR-Nigeria.
The key highlight of the training was on technology transfer on the use of MinION for the complete genome sequencing of SARS-CoV-2 recovered from nasopharyngeal samples of Nigerian COVID-19 patients and set the stage for genomic research collaborations on other infectious diseases of public health importance in Nigeria, including Malaria, Pneumonia,HIV & Diarrhea.
It also heralded the need for regular research exchange visits between researchers in NIMR and MRC, the Gambia.
The Institut Mérieux has been committed for many years in the fight against Antimicrobial Resistance (AMR) and improvement of antibiotic stewardship.
The Institut Mérieux has been committed for many years in the fight against Antimicrobial Resistance (AMR) and improvement of antibiotic stewardship. Antimicrobial resistance (AMR) is a major public health issue worldwide and this aligns with the mandate of NIMR to conduct research into health problems in Nigeria with a focus on Communicable Diseases of Public Health importance in the country.
The Institute Merieux in partnership with the Nigerian Institute of Medical Research will provide an incentive for promising young investigators working in the field of AMR in Nigeria by financing research based on the provision of grants and awards to enable high value-added research projects to be conducted.
The focus is on researchers or clinicians at the beginning of their career in recognition of a major achievement having significant impact on the handling of AMR and more globally on infectious disease diagnostics.
Institut Mérieux and Nigerian Institute of Medical Research have decided to allocate in 2021 a joint Young Investigator Award of 10,000 €, that will be given to the laureate during NIMR Annual Scientific Conference.
Selection criteria
Selection process and Conditions.
Adolescent Engagement in HIV Research in Africa: A crowdsourcing open call
Adolescents across Africa are engaging in HIV research in innovative ways, setting a new standard for meaningful research engagement. In partnership with the Adolescent HIV Prevention and Treatment Implementation Science Alliance, our team is organizing a crowdsourcing open call. The purpose of the open call is to solicit creative ways that adolescents (14-24 years old) have participated in HIV research studies in Africa. Adolescents who submit exceptional texts, images, or videos will receive prizes.
Deadline for submissions is 31 January 2021.
Contact Kadija at africayouthopencall@gmail.com if you have any questions.
Contact Kadija at africayouthopencall@gmail.com if you have any questions.
Malaria control gained traction after the introduction of artemisinin-based combination treatment. Unfortunately, artemisinin (ART) resistance has been reported in South-East Asia (SEA) and there are emerging reports of delayed ART sensitivity in African parasites, suggesting imminent treatment failure. As replacement antimalarial drugs are yet unavailable, monitoring artemisinin resistance in African parasites and understanding the markers of such adaptation will be important to stop resistance in its tracks. Kelch-13 gene mutations are the markers of ART resistance in SEA. However, these markers do not provide phenotypic evidence of resistance in African isolates. This suggests that mechanisms driving ART tolerance in African parasites could be independent of Kelch-13 markers. In this study, we will assess the efficacy of artemether-lumefantrine for the treatment of Plasmodium falciparum in their natural human hosts and in vitro. The public health implications of ART-based treatment failure make this proposal very crucial for early detection of ART-tolerant malaria parasites in the country.
